Upregulation of glutamate transporter GLT-1 by mTOR-Akt-NF-кB cascade in astrocytic oxygen-glucose deprivation (Q28576235)

31 January 2017

title

Upregulation of glutamate transporter GLT-1 by mTOR-Akt-NF-кB cascade in astrocytic oxygen-glucose deprivation (English)

1 reference

31 January 2017

0 references

Yi-Fei Ji

1

1 reference

31 January 2017

Liang Zhou

2

1 reference

31 January 2017

Ya-Jun Xie

3

1 reference

31 January 2017

Si-Min Xu

4

1 reference

31 January 2017

Jia Zhu

5

1 reference

31 January 2017

Peng Teng

6

1 reference

31 January 2017

Chong-Yu Shao

7

1 reference

31 January 2017

Yin Wang

8

1 reference

31 January 2017

Jian-Hong Luo

9

1 reference

31 January 2017

Ying Shen

10

1 reference

31 January 2017

publication date

1 December 2013

1 reference

31 January 2017

1 reference

31 January 2017

volume

61

1 reference

31 January 2017

issue

12

1 reference

31 January 2017

page(s)

1959–1975

1 reference

Neuronal activity regulates glutamate transporter dynamics in developing astrocytes

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

21 January 2018

The two TORCs and Akt.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Targeting the mTOR signaling network in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Transient cerebral ischemia induces active astrocytosis without distinct neuronal death in the gerbil main olfactory bulb: a long-term analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Rapamycin is a neuroprotective treatment for traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Reactive astrocytes protect tissue and preserve function after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

AMPK phosphorylation of raptor mediates a metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

The tripartite synapse: roles for gliotransmission in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

AMPK: a key sensor of fuel and energy status in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Glutamate transporters bring competition to the synapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Insulin increases glutamate transporter GLT1 in cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Selective blockade of astrocytic glutamate transporter GLT-1 with dihydrokainate prevents neuronal death during ouabain treatment of astrocyte/neuron cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Reversed operation of glutamate transporter GLT-1 is crucial to the development of preconditioning-induced ischemic tolerance of neurons in neuron/astrocyte co-cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

mTOR signaling at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Transforming growth factor-α mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Decreased neuronal death in Na+/H+ exchanger isoform 1-null mice after in vitro and in vivo ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Cell surface turnover of the glutamate transporter GLT-1 is mediated by ubiquitination/deubiquitination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

The enemy at the gates. Ca2+ entry through TRPM7 channels and anoxic neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Localization of neuronal and glial glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

mTOR and cancer: insights into a complex relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Excitatory amino acid transporters: a family in flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Distinct functions of nuclear distribution proteins LIS1, Ndel1 and NudCL in regulating axonal mitochondrial transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Characterization of AMPA receptors on isolated amacrine-like cells in carp retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Rictor is a novel target of p70 S6 kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Molecular organization of target of rapamycin complex 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Chronic zinc exposure decreases the surface expression of NR2A-containing NMDA receptors in cultured hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Astrocytes protect neurons from hydrogen peroxide toxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Expression of glutamate transporters in cultured glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Neuronal regulation of glutamate transporter subtype expression in astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22566

7 January 2021

Identifiers

DOI

10.1002/GLIA.22566

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017